Honeywell announced Aclar Edge, a pharmaceutical packaging system for oral liquids for human health and sterile injectables for animal health applications. Designed with Honeywell’s proprietary multi-layer extrusion blow molding technology, Aclar Edge bottles and vials preserve shelf-life and efficacy for a wide variety of challenging liquid dosage forms while improving user safety during the handling and administration.
Aclar Edge bottles and vials provide a moisture barrier performance that is comparable with glass and an enhanced oxygen barrier compared to other polymeric containers. In addition, Aclar Edge offers impact resistance and up to 75% weight reduction versus glass. Aclar Edge offers significant operational advantages by eliminating glass cracking and breakage, minimizing drug particulate contamination and reducing transportation cost. Unlike many plastic bottles used for liquids, AclarEdge reduces the risk of leachables from the container closure systems.
Aclar Edge bottles and vials range in sizes from 100 ml to 500 ml and can be configured in threaded or crimped finish; commercial production will start in Q4 2020 for non-sterilized or gamma-sterilized formats.
Pre-production samples of Aclar Edge are available now for customer evaluation.
